About: Kohzoh Imai     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Person, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FKohzoh_Imai&invfp=IFP_OFF&sas=SAME_AS_OFF

Kohzoh Imai (今井浩三, Kohzoh Imai, born January 1, 1948) is a Japanese physician and oncologist specializing in molecular diagnosis and novel medical treatment of cancer. He is well known for the discovery of a melanoma-related antigen (later, it is called, Chondroitin Sulfate Proteoglycan-4 (CSPG4)) by producing a monoclonal antibody. In addition, he produced monoclonal antibodies against CEA or ICAM-1 and found out they are usable in the diagnosis and the pathological analysis.

AttributesValues
rdf:type
rdfs:label
  • Kohzoh Imai (en)
  • 今井浩三 (ja)
rdfs:comment
  • 今井 浩三(いまい こうぞう、1948年1月1日 - )は、日本の医学者、札幌医科大学名誉教授、元・同大学長。元・北海道公立大学法人札幌医科大学理事長。内科医で癌(がん)の研究者。癌の分子診断や新しい治療が専門。日本学術会議会員(20,21期)、2009年、春の園遊会に招待。2010年、東京大学教授(東京大学医科学研究所附属病院第19代病院長)。2013年、紫綬褒章受章。2014年、東京大学特任教授(東京大学医科学研究所医療イノベーション推進室長)、神奈川県立がんセンター臨床研究所長。2016年、東京大学客員教授、東京大学医科学研究所 学術研究基盤支援室長。2019年、日本医療研究開発機構(AMED)プログラムオフィサー。 (ja)
  • Kohzoh Imai (今井浩三, Kohzoh Imai, born January 1, 1948) is a Japanese physician and oncologist specializing in molecular diagnosis and novel medical treatment of cancer. He is well known for the discovery of a melanoma-related antigen (later, it is called, Chondroitin Sulfate Proteoglycan-4 (CSPG4)) by producing a monoclonal antibody. In addition, he produced monoclonal antibodies against CEA or ICAM-1 and found out they are usable in the diagnosis and the pathological analysis. (en)
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
has abstract
  • Kohzoh Imai (今井浩三, Kohzoh Imai, born January 1, 1948) is a Japanese physician and oncologist specializing in molecular diagnosis and novel medical treatment of cancer. He is well known for the discovery of a melanoma-related antigen (later, it is called, Chondroitin Sulfate Proteoglycan-4 (CSPG4)) by producing a monoclonal antibody. In addition, he produced monoclonal antibodies against CEA or ICAM-1 and found out they are usable in the diagnosis and the pathological analysis. He is a former professor and president of Sapporo Medical University. He was a Council Member of the Science Council of Japan (The 20th and 21st term). Also he was invited by the Emperor and Empress to their spring garden party in 2009. He was a professor and the director at Research Hospital, The Institute of Medical Science, the University of Tokyo in 2010 and is currently a project professor at the University of Tokyo and the director of Kanagawa Cancer Center Research Institute in 2014 to present. He received the Medal of Honor with Purple Ribbon in 2013. (en)
  • 今井 浩三(いまい こうぞう、1948年1月1日 - )は、日本の医学者、札幌医科大学名誉教授、元・同大学長。元・北海道公立大学法人札幌医科大学理事長。内科医で癌(がん)の研究者。癌の分子診断や新しい治療が専門。日本学術会議会員(20,21期)、2009年、春の園遊会に招待。2010年、東京大学教授(東京大学医科学研究所附属病院第19代病院長)。2013年、紫綬褒章受章。2014年、東京大学特任教授(東京大学医科学研究所医療イノベーション推進室長)、神奈川県立がんセンター臨床研究所長。2016年、東京大学客員教授、東京大学医科学研究所 学術研究基盤支援室長。2019年、日本医療研究開発機構(AMED)プログラムオフィサー。 (ja)
gold:hypernym
schema:sameAs
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage disambiguates of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 63 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software